Publications On CV Disease Prevention

Novel Observations and Discoveries made by
the Cardiovascular Disease Assessment Center of Sarasota
in the area of Cardiovascular Disease Prevention,
presented at National and International Medical Meetings:

  1. Early Cardiovascular Disease Risk Score As A More Sensitive Guide Than Framingham Score For Cardiovascular Risk Prediction In Males And Its Correlation With Hypertension; presented at the 2009 American Society of Hypertension Annual Scientific Meeting, San Francisco, California, May 2009
  2. Time to Mandate a More Accurate Tool to Assess CVD risk in   Women Beyond Framingham; presented at the International Conference for Early Disease Detection   and Prevention (EDDP), Munich, Germany, February 2010
  3. Why Early Screening For CVD Risk Stratification With A More Accurate Risk Score Method Must Be Mandated By Those Who Care About Our Health? - oral presentation; presented at the International Conference for Early Disease Detection and Prevention (EDDP), Munich, Germany, February 2010
  4. Rise  In Systolic Blood Pressure (SBB) Over 30 mmHg After Mild Exercise as a New Marker for  Early Cardiovascular Disease Risk Stratification in Asymptomatic Normotensive Patients Regardless of Sex - oral presentation; presented at the International Conference for Early Disease Detection and Prevention (EDDP), Munich, Germany, February 2010
  5. Carotid Intima Medial Thickness (CIMT) Measurement For Cardiovascular Disease (CVD) Risk Stratification In Newly Diagnosed Asymptomatic Hypertensive Patients, presented at the 2010 American Society of Hypertension Annual Scientific Meeting, New York, NY, May 2010;
  6. Carotid Intima Medial Thickness (CIMT) and small artery elasticity (C2) as a powerful tool  for Cardiovascular Disease (CVD) risk stratification as compared with  high-sensitivityC- reactive protein (hCRP)  regardless of sex - oral presentation; presented at the International Academy Of Cardiology 15th World Congress on Heart Disease Annual Scientific Sessions 2010,Vancouver, B.C., Canada, July 24-27, 2010;
  7. Novel approaches for risk stratification and management of asymptomatic Metabolic Syndrome subjects:  is Metabolic Syndrome a marker of Coronary Artery disease in all?; presented at the Fifth Annual Scientific Meeting of the Society for Cardiovascular Computed Tomography [SCCT'] July 15-18, 2010;
  8. Value of Pro BNP as a Screening Tool for the Assessment of Early Cardiovascular Disease Risk Assessment; presented at the American College of Physicians, Florida Chapter Associate Meeting, Orlando, FL, March 11-13th, 2011
  9. Abnormal  Systolic Blood Pressure Rise Post Exercise as a Marker for Early Cardiovascular   Disease Risk assessment in Asymptomatic Normotensive Subjects, presented at the American College of Physicians, Florida Chapter Associate Meeting , Orlando, FL, March 11-13th, 2011
  10. Is metabolic syndrome cardiovascular disease (CVD) risk equivalent?; presented at the  European Society of Cardiology (ESC) EuroPRevent Annual Meeting, Geneva, Switzerland,  April 2011.
  11. Predictors of early cardiovascular disease risk in asymptomatic Metabolic Syndrome    individuals: Which test is best?; to be presented at the AHA Quality Care and Outcomes Research in Cardiovascular Disease and Stroke 2011 Scientific Sessions, Washington, DC, May 2011;
  12. Pre-Hypertension: is it a disease? - presented at the American Society of Hypertension 2011 Annual Scientific  Meeting, New York, NY, May 2011;
  13. Novel method for assessing the prevalence of Hypertension and Cardiovascular Disease  Risk in a Community Screening Program in a South East Region of US - presented at the  American Society of Hypertension 2011 Annual Scientific Meeting, New York, NY, May 2011;
  14. Is Epicardial Fat Volume Gender Specific? Is Its Excess a Villain for Cardiovascular Disease Risk in Metabolic Syndrome subjects? To be presented at the 6th Annual Scientific Meeting of the Society of Cardiovascular Computed Tomography, July 2011, Denver, Colorado
  15. Obesity and cardiovascular disease (CVD): an association or a cause and effect relationship?- presented at 2011 Annual meeting of the European Society of  Cardiology, August , 2011, Paris, France
  16. The Value of Optimal Blood Pressure Control in Reducing Functional and Structural Cardiovascular Abnormalities , presented at 15th Annual Scientific meeting of the Heart Failure Society of America September 18-21,2011 Boston, MA
  17. Obesity Even Without Comorbidity Is A Risk Marker For Stroke, presented at the AHA International Stroke Conference, February 1-3, 2012, New Orleans, Louisiana
  18. What are the early cardiovascular (CV) structural and functional abnormalities associated with obesity?, presented at the Heart Failure 2012 Congress - held in Belgrade Serbia, 19-22 May 2012.
  19. Obesity Even Without Co-morbidity Harbors more Cardiovascular Structural and  Functional Abnormalities than what you think! Time for Early CV Screening!, presented at the Quality of Care and Outcomes Research 2012 Scientific Sessions in Atlanta, GA, May 9-11, 2012. 
  20. Cardiovascular disease is the number one killer in the United States. It is time to look beyond Framingham risk Score for alternative 21st century risk scoring system!, presented at the American Society of Hypertension 2012 Annual Scientific  Meeting, New York, NY, May 2012;
  21. Abnormal blood pressure rise post mild exercise in hypertensive patients is an additive risk factor, presented at the American Society of Hypertension 2012 Annual Scientific  Meeting, New York, NY, May 2012;
  22. Cardiovascular disease is the number one killer in the united states. It is time to look beyond Framingham risk Score for alternative 21st century risk scoring system!, presented at the American Society of Hypertension 2012 Annual Scientific  Meeting, New York, NY, May 2012;
  23. Beware of the Presence of Coronary Artery Calcification on Any Imaging Procedure! - Presented at the American Society of Cardiovascular Computed Tomography 7th Annual Scientific Meeting, Baltimore, MD, July 20th, 2012
  24. Abnormal blood pressure rise post mild exercise protocol in newly diagnosed hypertensive subjects is associated with significant cardiovascular functional/structural abnormalities – Presented at the European Society of Cardiology Annual Scientific Meeting, Munich, Germany, August 28th, 2012
  25. Perivascular Adipose Tissue and/or Epicardial Adiposity in Asymptomatic Obese Subjects is More Than a Scaffold: It is a Risk Marker for Cerebrovascular and Coronary Artery Disease, to be presented at the AHA Epidemiology and Prevention/Nutrition, Physical Activity and Metabolism 2013 Scientific Sessions, scheduled for March 19-22, 2013 at the New Orleans Marriott in New Orleans, LA
  26. Abnormal BP rise post mild exercise is a novel risk stratifier regardless of baseline untreated BP level in normotensive, pre-hypertensive or hypertensive subjects, to be presented at the European Society of Cardiology (ESC) EuroPRevent 2013 Annual Meeting  scheduled for Apr. 18 – 20, 2013, in Rome - Italy

 For a complete, up to date list, Please see Curriculum Vitae.